Acasti Pharma Probability of Future Stock Price Finishing Under 3.2
| ACSTDelisted Stock | USD 3.37 0.01 0.30% |
Acasti |
Acasti Pharma Target Price Odds to finish below 3.2
The tendency of Acasti Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 3.20 or more in 90 days |
| 3.37 | 90 days | 3.20 | about 87.68 |
Based on a normal probability distribution, the odds of Acasti Pharma to drop to $ 3.20 or more in 90 days from now is about 87.68 (This Acasti Pharma probability density function shows the probability of Acasti Stock to fall within a particular range of prices over 90 days) . Probability of Acasti Pharma price to stay between $ 3.20 and its current price of $3.37 at the end of the 90-day period is about 7.01 .
Given the investment horizon of 90 days Acasti Pharma has a beta of 0.41. This suggests as returns on the market go up, Acasti Pharma average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Acasti Pharma will be expected to be much smaller as well. Additionally Acasti Pharma has an alpha of 0.2957, implying that it can generate a 0.3 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Acasti Pharma Price Density |
| Price |
Predictive Modules for Acasti Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Acasti Pharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Acasti Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Acasti Pharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Acasti Pharma is not an exception. The market had few large corrections towards the Acasti Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Acasti Pharma, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Acasti Pharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.30 | |
β | Beta against Dow Jones | 0.41 | |
σ | Overall volatility | 0.37 | |
Ir | Information ratio | 0.05 |
Acasti Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Acasti Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Acasti Pharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Acasti Pharma is now traded under the symbol GRCE. Please update your portfolios or report it if you believe this is an error. Report It! | |
| Acasti Pharma is not yet fully synchronised with the market data | |
| Acasti Pharma appears to be risky and price may revert if volatility continues | |
| Acasti Pharma has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (12.85 M) with profit before overhead, payroll, taxes, and interest of 120 K. | |
| Acasti Pharma currently holds about 38.39 M in cash with (12.33 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.86. | |
| Roughly 38.0% of the company shares are held by company insiders |
Acasti Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Acasti Stock often depends not only on the future outlook of the current and potential Acasti Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Acasti Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 9.5 M | |
| Cash And Short Term Investments | 23 M |
Acasti Pharma Technical Analysis
Acasti Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. Acasti Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Acasti Pharma. In general, you should focus on analyzing Acasti Stock price patterns and their correlations with different microeconomic environments and drivers.
Acasti Pharma Predictive Forecast Models
Acasti Pharma's time-series forecasting models is one of many Acasti Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Acasti Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Acasti Pharma
Checking the ongoing alerts about Acasti Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Acasti Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Acasti Pharma is now traded under the symbol GRCE. Please update your portfolios or report it if you believe this is an error. Report It! | |
| Acasti Pharma is not yet fully synchronised with the market data | |
| Acasti Pharma appears to be risky and price may revert if volatility continues | |
| Acasti Pharma has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (12.85 M) with profit before overhead, payroll, taxes, and interest of 120 K. | |
| Acasti Pharma currently holds about 38.39 M in cash with (12.33 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.86. | |
| Roughly 38.0% of the company shares are held by company insiders |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Consideration for investing in Acasti Stock
If you are still planning to invest in Acasti Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acasti Pharma's history and understand the potential risks before investing.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |